IGF1 and schizophrenia: Therefore, the aim of our meta‐analysis was to investigate if there is a significant difference in peripheral IGF‐1 levels between schizophrenia patients and healthy controls, as well as to determine whether a difference in peripheral IGF‐1 levels exists before and after initiation of antipsychotic treatment.